Researchers have reported that a single cancer cell has enough power to develop a separate cancerous tumor. Dr Sean Morrison led a team of researchers from the Howard Hughes Medical Institute and the University of Michigan reported their findings in ...
Read more...
NOTTINGHAM, England, Dec. 4 (UPI) -- British and U.S. medical scientists say they have identified a gene that protects the body from developing lung cancer. Researchers from the University of Nottingham and Washington University in St. Louis said ...
Read more...
LOS ANGELES, Dec. 4 (UPI) -- A breast cancer chemotherapy drug shows benefits in fighting one type of breast cancer but not another type, U.S. researchers say. The study, published in the journal Clinical Cancer Research, found the oral chemotherapy ...
Read more...
NEW YORK (Reuters Health) - Among United States Latinas, a greater degree of European genetic ancestry is associated with an increased risk of breast cancer, the results of a new study indicate. This could be due to environmental factors, genetic ...
Read more...
LONDON - The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday. The findings could lead to new tests to ...
Read more...
In partnership with the Ukrop's Monument Avenue 10k, Massey Cancer Center is inviting the community to join the 2009 Massey Fundraising Challenge and "Put Cancer on the Run!" This is the fourth year the Massey Fundraising Challenge has been offered ...
Read more...
BURLINGTON, N.C., Dec. 4 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) , announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint ...
Read more...
Medical device maker Becton Dickinson and Co. said Thursday it received Food and Drug Administration clearance to sell a new cervical cancer screening system. The system, BD FocalPoint GS, uses the company's SurePath pap test slides. Its guided ...
Read more...
NEW ROCHELLE, N.Y. , Dec. 4 /PRNewswire/ -- Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic ...
Read more...
A Hampton dad-of-two diagnosed with bowel cancer is urging people not to let embarrassment get in the way of potentially lifesaving check-ups. Gary Flynn, 43, who was diagnosed with the disease in July, is now supporting a national campaign by ...
Read more...